Yusuke Nakamura to Oligonucleotides, Antisense
This is a "connection" page, showing publications Yusuke Nakamura has written about Oligonucleotides, Antisense.
Connection Strength
0.216
-
Isolation of development and differentiation enhancing factor-like 1 (DDEFL1) as a drug target for hepatocellular carcinomas. Int J Oncol. 2004 Jan; 24(1):43-8.
Score: 0.060
-
Identification of COX17 as a therapeutic target for non-small cell lung cancer. Cancer Res. 2003 Nov 01; 63(21):7038-41.
Score: 0.059
-
Isolation and characterization of a novel human gene, VANGL1, as a therapeutic target for hepatocellular carcinoma. Int J Oncol. 2002 Jun; 20(6):1173-8.
Score: 0.053
-
Aberrant laminin beta3 isoforms downstream of EWS-ETS fusion genes in Ewing family tumors. Cancer Biol Ther. 2005 Apr; 4(4):449-55.
Score: 0.016
-
Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses. J Hum Genet. 2004; 49(3):134-140.
Score: 0.015
-
Cyclin K as a direct transcriptional target of the p53 tumor suppressor. Neoplasia. 2002 May-Jun; 4(3):268-74.
Score: 0.013